CClinicalTrials.gg
RecruitingNCT05848752Updated May 18, 2026

Studies of Human Inference Using On-line Testing

An interventional study of psychophysics in Behavior, sponsored by University of Colorado, Boulder. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-18.

Sponsored by University of Colorado, Boulder · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Feb 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The investigators will record behavioral responses from human participants on crowdsourcing platform Prolific to identify the decision strategies humans apply short-term, long-term, and multi timescale (across both timescales) inference tasks. Participants will perform a flexible decision-making task (described in Research Strategy Aim 1) in which subjects must determine which of two locations a series of evidence (package drops) came from. Subjects must 1) report the current location, 2) predict the next location. The investigators will record these responses, the number (and sequence) of evidence, and the response time (time from the end of trial until the response) for each trial. Subjects will perform all blocks (parameters and number of blocks to be determined by inference model development and testing prior to task development) so that we can compare responses at each timescale. Since participants participate voluntarily for small sums of money (around $12/ hour based on duration of task) and the investigators' previous studies have collected over 200 subjects in a matter of days, they will aim to record behavioral data from 1000 subjects. This number allows them to address the broad range of subject variability expected using Bayesian statistical methods such as Bayes factors.

02

Conditions studied

  • Behavior

Browse trials for

03

In context

Behavior

371 studies on the registry are indexed under Behavior; 158 are open to participants now.

This study's planned enrollment of 500 is above the median of 120 across 295 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

University of Colorado, Boulder is the lead sponsor of 86 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Adult Prolific participants who have a 95% approval rating and achieve a minimum score of 80% on our pre-test,
  • Speak fluent English
  • Are in the US.

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    Environmental Feature Experiment

    Behavioral: psychophysics

Interventions

  • Behavioralpsychophysics

    Subjects will be shown two locations and a series of package drops that switch between the two locations with an unknown frequency. Subjects must identify which location is current in use and which location will be selected next. Subjects know that the frequency of the location changes is different in each block but not its exact value

06

What researchers measure

Primary outcomes

  1. Binary Behavioral Decision Responses

    Subject- provided choices (responses on the computer) between two presented options

    Time frame: Through task completion on each task trial, approximately 1-5x/ minute for approximate 30 minutes

07

Study locations

1 of 1 sites recruiting
  • University of Colorado Boulder
    Boulder, Colorado 80309, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The task structure will be preregistered to Open Science Framework (OSF) prior to data acquisition. De-identified data will be posted to OSF following publication.

Supporting information: Study protocol, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05848752
Lead sponsor
University of Colorado, Boulder
Collaborators
University of Pennsylvania
Responsible party
Tahra Eissa (Assistant Professor, University of Colorado, Denver) — Principal investigator
First posted
May 8, 2023
Start date
Feb 15, 2025
Primary completion
Aug 1, 2026 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
May 18, 2026

Study contacts

Tahra Eissa
Contact
tahra.eissa@colorado.edu
(303) 492-6974
Tahra Eissa
principal investigator · University of Colorado, Denver

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion